1-3 of 3
Jose Antonio Pérez-Simón
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGvHD biomarkers.

Open Access
Teresa Caballero-Velázquez, Javier Delgado-Serrano, Lucia López-Corral, Christelle Ferrá i Coll, Clara Beatriz García-Calderón, David Valcárcel, Irene García Cadenas, Estefanía Pérez López, Maria-Jose Jimenez, Francisco Manuel Martín-Domínguez, María de los Reyes Jiménez-Leon, Guillermo Orti, Virginia Escamilla Gómez, Cristina Blázquez-Goñi, Almudena Cabero Martínez, Henry Antonio Andrade Ruiz, Estefanía Menéndez-Pedregal, Fermín M Sánchez-Guijo, Jose Antonio Pérez-Simón
Journal: Blood Advances
Blood Adv bloodadvances.2025016284.
https://doi.org/10.1182/bloodadvances.2025016284
Published: 2025
Includes: Supplemental data
Journal Articles

Frontline allo-SCT in MRD-negative, intermediate-risk AML

Open Access
Eduardo Rodríguez-Arbolí, Teresa Caballero-Velázquez, Cristina Marrero-Cepeda, José Antonio Pérez-Simón
Journal: Blood Advances
Blood Adv bloodadvances.2025016610.
https://doi.org/10.1182/bloodadvances.2025016610
Published: 2025
Journal Articles

Autologous stem cell transplantation in T-cell/histiocyte-rich large B-cell lymphoma: EBMT Lymphoma Working Party study

Free
Clinical Trials & Observations
Simon Renders, Maud Ngoya, Herve Finel, Marie-Thérèse Rubio, William Townsend, Roland Schroers, Urban Novak, Nicolaas Schaap, Mahmoud Aljurf, Grzegorz Helbig, Matthew Collin, Guido Kobbe, Anne Huynh, José Antonio Pérez-Simón, Adrian Bloor, Hervé Ghesquieres, Anna Sureda, Norbert Schmitz, Bertram Glass, Peter Dreger
Journal: Blood Advances
Blood Adv (2024) 8 (21): 5571–5578.
https://doi.org/10.1182/bloodadvances.2024013152
Published: 2024
Includes: Supplemental data